journal article·2020Open access

Development of functional liposomes by modification of stimuli-responsive materials and their biomedical applications

Eiji Yuba

Abstract

Liposomes are a promising nanocarrier for drug delivery because of their biocompatibility and the encapsulation capacity of drugs. Liposomes can be functionalized easily by introduction of functional materials such as stimulus-responsive materials. Temperature-responsive liposomes and pH-responsive liposomes are representative stimulus-responsive liposomes that can deliver drugs to locally heated target tissues and intracellular organelles. Here, temperature-responsive liposomes for the selective release of cargo and pH-responsive liposomes for the induction of antigen-specific immunity are overviewed. Temperature-responsive polymer-modified liposomes immediately released drugs in response to heating, which achieved selective drug release at a tumour after topical heating of tumour-bearing mice. Introduction of MR-detectable molecules enabled the tracing of liposome accumulation into target sites to optimize the heating timing. These liposomes can also be combined with magnetic nanoparticles or carbon nanomaterials to attain magnetic field-responsive, electric field-responsive and light-responsive properties to support on-demand drug release or control of biological reactions using these external stimuli. pH-Responsive liposomes were produced by modification of poly(carboxylic acid) derivatives or by pH-responsive amphiphiles. These liposomes delivered antigenic proteins into the cytosol of antigen presenting cells, which induced cross-presentation and antigen-specific cellular immunity. Adjuvant molecules or bioactive polysaccharide-based pH-responsive polymers improved their immunity-inducing effect further, leading to tumour regression in tumour-bearing mice. Precise design and control of the structures of stimulus-responsive materials and combination with functional materials are expected to create novel methodologies to control biological functions and to produce highly potent liposomal drugs that can achieve selective release of bioactive molecules.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Applied Chemistry

Graduate School of Engineering

Osaka Prefecture University

Sakai

Japan

Funding

Japan Society for the Promotion of Science

References (100+)

Show source-provided references
1. Kintzing · Trends Pharmacol. Sci. · 2016 · 37 · 99310.1016/j.tips.2016.10.005 ↗
2. Beck · Nat. Rev. Drug Discovery · 2017 · 16 · 31510.1038/nrd.2016.268 ↗
3. Hodi · N. Engl. J. Med. · 2010 · 363 · 71110.1056/NEJMoa1003466 ↗
4. Hugo · Cell · 2016 · 165 · 3510.1016/j.cell.2016.02.065 ↗
5. Rizvi · Science · 2015 · 348 · 12410.1126/science.aaa1348 ↗
6. Tumeh · Nature · 2014 · 515 · 56810.1038/nature13954 ↗
7. Mura · Nat. Mater. · 2013 · 12 · 99110.1038/nmat3776 ↗
8. Karimi · Chem. Soc. Rev. · 2016 · 45 · 145710.1039/C5CS00798D ↗
9. Liu · Mater. Sci. Eng., C · 2017 · 71 · 126710.1016/j.msec.2016.11.030 ↗
10. Allen · Adv. Drug Delivery Rev. · 2013 · 65 · 3610.1016/j.addr.2012.09.037 ↗
11. Bobo · Pharm. Res. · 2016 · 33 · 237310.1007/s11095-016-1958-5 ↗
12. Bulbake · Pharmaceutics · 2017 · 9 · E1210.3390/pharmaceutics9020012 ↗
13. Barenholz · J. Controlled Release · 2012 · 160 · 11710.1016/j.jconrel.2012.03.020 ↗
14. Petersen · J. Controlled Release · 2016 · 232 · 25510.1016/j.jconrel.2016.04.028 ↗
15. Lee · Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. · 2017 · 9 · e1450
16. Kono · Adv. Drug Delivery Rev. · 2001 · 53 · 30710.1016/S0169-409X(01)00204-6 ↗
17. Heidarlia · Iran. J. Pharm. Res. · 2017 · 16 · 1273
18. Riaz · Int. J. Mol. Sci. · 2018 · 19 · 19510.3390/ijms19010195 ↗
19. Yatvin · Science · 1978 · 202 · 129010.1126/science.364652 ↗
20. D. Needham , Biomaterials for Cancer Therapeutics: Diagnosis, Prevention and Therapy , 2013 , pp. 270–348
21. Ho · J. Drug Targeting · 2018 · 26 · 40710.1080/1061186X.2017.1419361 ↗
22. Litzinger · Biochim. Biophys. Acta · 1992 · 1113 · 20110.1016/0304-4157(92)90039-D ↗
23. Ellens · Biochemistry · 1984 · 23 · 153210.1021/bi00302a029 ↗
24. Simões · Biochim. Biophys. Acta · 2001 · 1515 · 2310.1016/S0005-2736(01)00389-3 ↗
25. Heskins · J. Macromol. Sci., Part A: Pure Appl. Chem. · 1968 · 2 · 144110.1080/10601326808051910 ↗
26. Sánchez-Moreno · Nanomaterials · 2018 · 8 · 93510.3390/nano8110935 ↗
27. Guan · Soft Matter · 2011 · 7 · 637510.1039/c0sm01541e ↗
28. Nagase · Biomaterials · 2018 · 153 · 2710.1016/j.biomaterials.2017.10.026 ↗
29. Han · Eur. J. Pharm. Biopharm. · 2006 · 62 · 11010.1016/j.ejpb.2005.07.006 ↗
30. Hayashi · Bioconjugate Chem. · 1999 · 10 · 41210.1021/bc980111b ↗
31. Kono · Biochim. Biophys. Acta · 1999 · 1416 · 23910.1016/S0005-2736(98)00226-0 ↗
32. Yoshino · Bioconjugate Chem. · 2004 · 15 · 110210.1021/bc034205j ↗
33. Aoshima · J. Polym. Sci., Part A: Polym. Chem. · 1992 · 30 · 240710.1002/pola.1992.080301115 ↗
34. Kono · Bioconjugate Chem. · 2005 · 16 · 136710.1021/bc050004z ↗
35. Kono · Biomaterials · 2010 · 31 · 709610.1016/j.biomaterials.2010.05.045 ↗
36. Man · Mol. Imaging Biol. · 2018 · 20 · 68310.1007/s11307-018-1255-2 ↗
37. Mikhail · Magn. Reson. Imaging Clin. N. Am. · 2015 · 23 · 64310.1016/j.mric.2015.05.012 ↗
38. Kono · Biomaterials · 2011 · 32 · 138710.1016/j.biomaterials.2010.10.050 ↗
39. Kokuryo · Nanomedicine · 2015 · 11 · 22910.1016/j.nano.2014.09.001 ↗
40. Aoki · Transl. Res. · 2015 · 166 · 66010.1016/j.trsl.2015.07.009 ↗
41. Srinivasarao · Chem. Rev. · 2017 · 117 · 1213310.1021/acs.chemrev.7b00013 ↗
42. Biffi · Expert Opin. Drug Delivery · 2019 · 16 · 48110.1080/17425247.2019.1604679 ↗
43. Kono · J. Controlled Release · 2015 · 216 · 6910.1016/j.jconrel.2015.08.005 ↗
44. Haba · J. Am. Chem. Soc. · 2004 · 126 · 1276010.1021/ja047755g ↗
45. Haba · Macromolecules · 2006 · 39 · 745110.1021/ma061019a ↗
46. Haba · Angew. Chem., Int. Ed. · 2007 · 46 · 23410.1002/anie.200603346 ↗
47. Sideratou · Biomacromolecules · 2018 · 19 · 31510.1021/acs.biomac.7b01325 ↗
48. Kojima · J. Polym. Sci., Part A: Polym. Chem. · 2010 · 48 · 404710.1002/pola.24190 ↗
49. Kono · Angew. Chem., Int. Ed. · 2011 · 50 · 633210.1002/anie.201101007 ↗
50. Lajunen · J. Controlled Release · 2015 · 203 · 8510.1016/j.jconrel.2015.02.028 ↗
51. Wu · J. Am. Chem. Soc. · 2008 · 130 · 817510.1021/ja802656d ↗
52. Rengan · Nanoscale · 2014 · 6 · 91610.1039/C3NR04448C ↗
53. Salvatore · ACS Nano · 2016 · 10 · 774910.1021/acsnano.6b03194 ↗
54. Guo · J. Controlled Release · 2018 · 272 · 14510.1016/j.jconrel.2017.04.028 ↗
55. Katagiri · Small · 2011 · 7 · 168310.1002/smll.201002180 ↗
56. Miyako · Nat. Commun. · 2012 · 3 · 122610.1038/ncomms2233 ↗
57. Miyako · Angew. Chem., Int. Ed. · 2015 · 54 · 990310.1002/anie.201504987 ↗
58. Chechetka · Angew. Chem., Int. Ed. · 2016 · 55 · 647610.1002/anie.201602453 ↗
59. Swift · Soft Matter · 2016 · 12 · 254210.1039/C5SM02693H ↗
60. Felber · Adv. Drug Delivery Rev. · 2012 · 64 · 97910.1016/j.addr.2011.09.006 ↗
61. Seki · Macromolecules · 1984 · 17 · 169210.1021/ma00139a009 ↗
62. Murthy · J. Controlled Release · 1999 · 61 · 13710.1016/S0168-3659(99)00114-5 ↗
63. Harada · J. Biomater. Sci., Polym. Ed. · 2017 · 28 · 102510.1080/09205063.2017.1324551 ↗
64. Kono · Biochim. Biophys. Acta · 1994 · 1193 · 110.1016/0005-2736(94)90325-5 ↗
65. Kono · Biochim. Biophys. Acta · 1997 · 1325 · 14310.1016/S0005-2736(96)00244-1 ↗
66. Sakaguchi · Bioconjugate Chem. · 2008 · 19 · 104010.1021/bc7004736 ↗
67. Yuba · J. Controlled Release · 2011 · 149 · 7210.1016/j.jconrel.2010.03.001 ↗
68. Albert · J. Exp. Med. · 1998 · 188 · 135910.1084/jem.188.7.1359 ↗
69. Canton · Nat. Rev. Immunol. · 2013 · 13 · 62110.1038/nri3515 ↗
70. Banchereau · Nature · 1998 · 392 · 24510.1038/32588 ↗
71. Mellman · Cell · 2001 · 106 · 25510.1016/S0092-8674(01)00449-4 ↗
72. Fehres · Front. Immunol. · 2014 · 5 · 14910.3389/fimmu.2014.00149 ↗
73. Joffre · Nat. Rev. Immunol. · 2012 · 12 · 55710.1038/nri3254 ↗
74. Yuba · Mol. Immunol. · 2018 · 98 · 810.1016/j.molimm.2017.11.001 ↗
75. Yuba · Biomaterials · 2010 · 31 · 94310.1016/j.biomaterials.2009.10.006 ↗
76. Yuba · Biomaterials · 2013 · 34 · 304210.1016/j.biomaterials.2012.12.031 ↗
77. Hebishima · Clin. Vaccine Immunol. · 2012 · 19 · 149210.1128/CVI.00273-12 ↗
78. Watarai · Vet. Immunol. Immunopathol. · 2014 · 158 · 6210.1016/j.vetimm.2013.05.005 ↗
79. Steinhagen · Vaccine · 2011 · 29 · 334110.1016/j.vaccine.2010.08.002 ↗
80. Kaisho · Biochim. Biophys. Acta · 2002 · 1589 · 110.1016/S0167-4889(01)00182-3 ↗
81. Mata-Haro · Science · 2007 · 316 · 162810.1126/science.1138963 ↗
82. Yoshizaki · Biomaterials · 2017 · 141 · 27210.1016/j.biomaterials.2017.07.001 ↗
83. Yuba · Biomaterials · 2015 · 67 · 21410.1016/j.biomaterials.2015.07.031 ↗
84. Okazaki · J. Vet. Med. Sci. · 2018 · 80 · 19710.1292/jvms.17-0491 ↗
85. Lonez · Adv. Drug Delivery Rev. · 2012 · 64 · 174910.1016/j.addr.2012.05.009 ↗
86. Yan · Mol. Immunol. · 2007 · 44 · 367210.1016/j.molimm.2007.04.009 ↗
87. Chen · Cancer Immunol. Immunother. · 2008 · 57 · 51710.1007/s00262-007-0390-4 ↗
88. Chen · Mol. Pharmaceutics · 2008 · 5 · 46410.1021/mp700126c ↗
89. Yoshizaki · Biomaterials · 2014 · 35 · 818610.1016/j.biomaterials.2014.05.077 ↗
90. Yuba · Biomaterials · 2014 · 35 · 309110.1016/j.biomaterials.2013.12.024 ↗
91. Yuba · Membranes · 2017 · 7 · 4110.3390/membranes7030041 ↗
92. Okubo · Bioconjugate Chem. · 2019 · 30 · 151810.1021/acs.bioconjchem.9b00221 ↗
93. Miyazaki · ACS Biomater. Sci. Eng. · 2019 · 5 · 579010.1021/acsbiomaterials.9b01278 ↗
94. Miyazaki · Bioconjugate Chem. · 2018 · 29 · 4410.1021/acs.bioconjchem.7b00551 ↗
95. Kataoka · J. Biol. Chem. · 2002 · 277 · 3682510.1074/jbc.M206756200 ↗
96. McGreal · Glycobiology · 2006 · 16 · 42210.1093/glycob/cwj077 ↗
97. Sukhithasri · Microbiol. Res. · 2013 · 168 · 39610.1016/j.micres.2013.02.005 ↗
98. Yuba · Biomaterials · 2017 · 120 · 3210.1016/j.biomaterials.2016.12.021 ↗
99. Doura · Langmuir · 2015 · 31 · 510510.1021/acs.langmuir.5b00183 ↗
100. Dusko · Macromolecules · 2003 · 36 · 420110.1021/ma0300241 ↗